Search

Ramipril Recall Due to Packaging Error

The MHRA has issued a precautionary recall for one batch of Ramipril 5 mg Capsules (Batch Number GR164099) due to a packaging error that may have resulted in Amlodipine 5 mg Tablets being included in the cartons. Pharmacy and healthcare professionals are advised to return remaining stock to suppliers.

UK Agencies Support In-Orbit Pharmaceutical Manufacturing

The UK Space Agency, MHRA, RIO, and CAA have issued a joint statement outlining their support for companies involved in in-orbit pharmaceutical manufacturing. This initiative aims to foster a supportive regulatory environment through guidance and collaborative studies, reinforcing the UK's commitment to space-enabled manufacturing.

BMW Motorcycle Recall - Turn Signals May Not Work

Transport Canada has issued a recall for BMW motorcycles due to a potential defect in the left combination switch, which may prevent turn signals from functioning. The issue poses a safety risk, as non-functional turn signals could increase the risk of a crash. Affected motorcycles have not yet been delivered to customers.

International Motors Bus Recall - Brake Line Issue

Transport Canada has issued a recall for certain 2025-2026 IC BUS CE COMMERCIAL BUS models manufactured by International Motors due to a potential brake line issue. The recall addresses the risk of reduced braking performance, increasing the risk of a crash.

Honda and Acura SUV Recall - Instrument Cluster Display Issue

Transport Canada has issued a recall for 2024 Honda Prologue and Acura ZDX SUVs due to a software issue that can cause the instrument cluster and infotainment display to go blank while driving. This poses a safety risk by preventing drivers from seeing critical information and the rearview camera.

International Motors School Bus Brake Lines Recalled

Transport Canada has issued a recall for International Motors school buses due to a potential issue with brake lines not being secured correctly. This could lead to brake fluid leaks and reduced braking capability, increasing the risk of a crash. Owners will be notified to have the brake lines inspected and replaced.

Illinois Releases Carbon Monoxide Surveillance Report

The Illinois Department of Public Health has released its first carbon monoxide surveillance report, detailing unintentional CO exposures from 2019-2023. The report highlights an average of 940 ED visits, 126 hospital admissions, and nearly 57 deaths annually, aiming to strengthen prevention and awareness efforts.

Illinois Tax Season Public Health Voluntary Contribution Program

The Illinois Department of Public Health (IDPH) is reminding taxpayers about the voluntary contribution program available when filing their state tax returns. Taxpayers can designate a portion of their refund to support various health-related funds, including those for Alzheimer's research, diabetes research, and assistance for the homeless.

Draft Guidance: Responding to FDA Form 483 Observations for Drug Manufacturers

The FDA has issued draft guidance for drug manufacturers on how to respond to observations noted on FDA Form 483 following CGMP inspections. This guidance is intended to assist domestic and foreign manufacturers in assessing conformity with CGMP requirements.

Health product recall: APO-BRIMONIDINE-TIMOP weight out of specification

Health Canada has issued a recall for APO-BRIMONIDINE-TIMOP due to a weight specification issue in lot VK2312. The recall is classified as Type II, indicating a low probability of adverse health consequences. Retailers are instructed to remove the affected product from shelves.